Company News

High Force Research welcomes new team member to expanded lab After completing a PhD sponsored by the company, David Chisolm will work on vitamin A and retinoic acid for neurodegenerative diseases Reinhard Kandera appointed CFO of Hookipa Biotech Paul Ingall joins Yamato to drive new spare parts business Agility Health announces retirement of CEO Ergomed Board and Management changes Destiny Pharma appoints Neil Clark new CEO Bill Love, Destiny’s founder, to become Chief Scientific Officer Ivan Gonzalez appointed Technical Director of Jet Environmental Emerson announces new President for Branson New Executive VP at Recipharm CARE Lifetime Achievement Award goes to Michael Murphy, Worldwide Clinical Trials Clinical Research and Excellence 2017 Lifetime Achievement Award recognises Murphy for his dedication for driving excellence in clinical research Bioiberica names Luis Solera new CEO Intelligent Fingerprinting appoints Director of Quality Martin Payne brings 20 years’ senior Quality Assurance and Regulatory Affairs experience Aelix appoints Ian McGowan as CMO HIV expert will support company in advancing therapeutic HIV vaccine to clinical proof-of-concept Allecra Therapeutics appoints new Chair and CMO Bill Sibold becomes Sanofi's Executive VP Sanofi appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee Raymond Barlow takes up role as CEO of e-Therapeutics

Trending Articles

  1. DFE Pharma appoints Khatera Alawi as new Global Director Human Resources An experienced international HR leader, Alawi joins DFE Pharma’s Leadership Team to support the company’s people-centric, high-performance culture
  2. IMCD appoints Vlad Miller as president, US Vlad Miller takes on the role of President, US, following five months leading the business on an interim basis
  3. ACG appoints Lalit Kasliwal as Group Chief Financial Officer New appointment to support ACG’s next phase of international growth
  4. FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence FUJIFILM Biotechnologies today announced a planned leadership evolution as the Company enters its next phase of execution and sustainable growth
  5. Actimed strengthens board with appointment of Dr Anders Ullman Pharmaceutical executive brings more than 30 years of international drug development and corporate leadership experience

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all